Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)

NCT04107727 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

273

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Quizartinib
DRUG: Placebo oral tablet
DRUG: Cytarabine
DRUG: Idarubicin

Sponsor

PETHEMA Foundation

Collaborators

[object Object]
[object Object]